A research team led by Jackson Laboratory Professors Frank McKeon, Ph.D., and Wa Xian, Ph.D., reports on the role of certain lung stem cells in regenerating lungs damaged by disease.
The work, published Nov. 12 in the journal Nature, sheds… Read more →
These are exciting times for regenerative medicine. Unlike conventional medicines, the regenerative approach can potentially work to restore the lost functionality of tissues or organs—the major reason for intensive focus on research and development in the field. The global market… Read more →
The first embryonic stem (ES) cell trial for severe heart failure is launching now in Paris. The long-awaited trial comes after much preclinical cell work on more than 350 rats, 50 immunodeficient mice and 32 non-human primates. “After 20 years… Read more →
Few diseases are as terrifying as Huntington’s, an inherited genetic disorder that gradually saps away at sufferers’ muscle control and cognitive capacity until they die (usually some 20 or so years after initial symptoms). But scientists at Washington University School… Read more →
A Bulgarian man who was paralyzed from the chest down in a knife attack can now walk with the aid of a frame after receiving pioneering transplant treatment using cells from his nose.
The technique, described as a breakthrough by… Read more →
“Imagine a world where energy is converted 10,000 times more efficiently than the sun, where batteries are alive and broken bridges rebuild themselves,” said Nina Tandon, founder of New York based tissue engineering start-up EpiBone, speaking at WIRED2014. This is a world, the… Read more →
Researchers have developed a technique to jump-start the body’s systems for creating blood vessels, opening the door for potential new treatments for diseases whose impacts include amputation and blindness.
The international team, led by scientists at the Indiana University School… Read more →
A ‘one-stop shop’ to provide regulatory advice on regenerative medicines has been launched in the UK.
The service will, for the first time, provide a single point of access to the four regulatory bodies that work in the sector –… Read more →
Cardio3 BioSciences (C3BS) (Euronext Brussels and Paris: CARD), a leader in the discovery, development and commercialization of regenerative, protective and reconstructive therapies, announces today the signing of a preferred access agreement with Mayo Clinic. Under this agreement, Mayo grants Cardio3… Read more →
As a partner in the EU-funded Bio-Bone project (Bioceramics for Bone Repair) Lucideon is pleased to announce that the pan-European consortium has successfully developed phosphate-glasses (p-glasses) with biomaterial properties for bone repair.
Lucideon’s materials and healthcare experts co-ordinated the biodegradation… Read more →